Veri Medtech (VRHI) Relaunches Veriheal.com
Rhea-AI Summary
Veri Medtech (VRHI) has announced the relaunch of its healthcare technology platform, Veriheal.com. The upgraded platform aims to strengthen the company's market leadership position by serving as a connector between patients and physicians through what they term an "infinite wellness loop."
CEO Sam Adetunji emphasized that the newly enhanced Veriheal.com platform will help extend the company's leadership positioning across its served markets. The announcement represents a strategic move to enhance the company's digital healthcare connectivity solutions.
The platform, accessible at www.Veriheal.com, focuses on facilitating healthcare connections and improving patient-physician relationships through technological innovation.
Positive
- Platform relaunch indicates technology upgrade and modernization
- Company maintains leadership position in its target markets
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, VRHI declined 14.57%, reflecting a significant negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Veri Medtech (Stock Ticker Symbol: “VRHI”) announced today that it has relaunched its Veriheal.com healthcare technology platform. For more information, please visit: www.Veriheal.com.
“Veri Medtech (VRHI) has established its proprietary Veriheal.com healthcare technology platform as a powerful connector bringing patients and physicians together via an infinite wellness loop. The newly-upgraded Veriheal.com serves to extend and further Veriheal’s leadership positioning throughout the markets that it serves," said Sam Adetunji, CEO, Veri Medtech Holdings.
About Veriheal: Veriheal, a wholly-owned subsidiary of publicly-traded Veri Medtech Holdings (Stock Ticker Symbol: “VRHI”) is a healthcare technology company on a mission to help real people get real medicine. For more information, please visit: www.Veriheal.com
About Veri Medtech Holdings, Inc. (OTC Markets – Stock Ticker Symbol: “VRHI”): Veri Medtech is a publicly-traded healthcare technology company that offers alternative medicine, personalized diagnostics, and wellness medication on demand. The company leverages telehealth infrastructure, diagnostic intelligence, and scalable digital systems to meet the growing demand for accessible, stigma-free healthcare. Strategically positioned for growth, Veri MedTech actively explores acquisitions that complement its core capabilities and enhance patient engagement across emerging sectors of alternative medicine, longevity, and wellness science. With a strong integration and operational efficiency track record, the company drives accelerated revenue through the continuous generation of high-value patient databases and recurring service models. With a commitment to innovation and patient-centric care, Veri MedTech continues to expand its services and reach, aiming to make personalized healthcare more accessible and effective for all. For more information, please visit: www.VeriMedTech.com
Forward Looking Statements: Cautionary Note Regarding Forward-Looking Statements: This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Veri Medtech (OTC: "VRHI") and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements.
Media Inquiries
pr@verimedtech.com